Valuation: Camurus AB

Market Cap 44.01B 4.31B 3.92B 3.62B 3.29B 6.17B 399B 6.48B 17.49B 218B 16.16B 15.82B 684B P/E 2026 *
44.5x
P/E 2027 * 32.8x
Enterprise Value 39.47B 3.86B 3.52B 3.24B 2.95B 5.53B 358B 5.82B 15.69B 195B 14.5B 14.19B 613B EV / Sales 2026 *
13.7x
EV / Sales 2027 * 10.4x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.07%
1 week-0.74%
Current month+9.88%
1 month+11.37%
3 months+17.38%
6 months+37.97%
Current year+20.05%
1 week 724.5
Extreme 724.5
750
1 month 657
Extreme 657
750
Current year 430.8
Extreme 430.8
750
1 year 430.8
Extreme 430.8
750
3 years 417.4
Extreme 417.4
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 31/12/2002
Director of Finance/CFO 57 30/06/2025
Chief Tech/Sci/R&D Officer 58 31/12/2024
Director TitleAgeSince
Director/Board Member 63 31/12/2001
Chairman 77 31/12/2014
Director/Board Member 61 06/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%-0.74%+20.34%+65.81% 4.31B
-0.30%-6.68%+29.12%+125.42% 1,200B
+1.25%-5.35%+33.19%+80.42% 651B
+0.94%-2.99%+24.73%+106.93% 506B
-0.60%-1.95%+27.26%+67.32% 377B
+0.69%-9.50%+40.80%+30.23% 330B
+0.41%-4.70%+27.23%+51.59% 288B
+0.81%-4.08%-1.74%+32.71% 272B
-0.15%-6.45%+29.63%+64.18% 236B
-0.06%-0.98%+33.15%+118.99% 206B
Average +0.33%-4.35%+26.37%+74.36% 407B
Weighted average by Cap. +0.40%-5.19%+28.02%+87.47%

Financials

2026 *2027 *
Net sales 2.87B 281M 256M 236M 215M 403M 26.06B 424M 1.14B 14.24B 1.06B 1.03B 44.68B 3.68B 360M 328M 302M 275M 516M 33.36B 542M 1.46B 18.22B 1.35B 1.32B 57.18B
Net income 995M 97.36M 88.68M 81.71M 74.33M 139M 9.02B 147M 395M 4.92B 365M 358M 15.46B 1.35B 132M 120M 111M 101M 189M 12.24B 199M 537M 6.69B 496M 486M 20.99B
Net Debt -4.54B -444M -405M -373M -339M -636M -41.15B -669M -1.8B -22.48B -1.67B -1.63B -70.54B -5.7B -558M -508M -468M -426M -799M -51.69B -840M -2.27B -28.23B -2.09B -2.05B -88.61B
Projected Income Statement - Annual - Camurus AB
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
323
Date Price Change Volume
20/11/26 SEK 739.50 -0.07% 74,888
19/11/26 SEK 740.00 +1.02% 81,316
18/11/26 SEK 732.50 +0.41% 112,765
17/11/26 SEK 729.50 -1.42% 87,957
16/11/26 SEK 740.00 -0.67% 103,116
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Camurus AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
739.50SEK
Average target price
850.00SEK
Spread / Average Target
+14.94%
  1. Stock Market
  2. Stocks
  3. CAMX Stock